{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/724-US10,975,364(Active) re (Done on website already).pdf"}, "page_content": "includes an alanine at the N413 position .\n\non - target site , on a target DNA molecule , thereby resulting\n\nIn another example embodiment , the modified protein\n\nin a double stranded chromosomal break at the on - target site\n\nincludes an amino acid sequence as defined in SEQ ID NO :\n\nthat leads to site - specific modifications by the cell . The 50 2 or a homologue thereof wherein the modified protein\n\n\" target gene \u201d as used herein refers to a gene of interest . The\n\ncomprising or consisting of the amino acid sequence\n\nCas9 protein recognizes a short DNA sequence , the proto-\n\nincludes three E782K , N968K , R1015H substitutions and a\n\nspacer adjustment motif ( PAM ) , found downstream of the\n\nmutation at an N413 position . In a preferred embodiment ,\n\ntarget sequence , usually three to four nucleotides down-\n\nthe modified protein comprising or consisting of the amino\n\nstream from the cut site . The PAM sequence is an essential 55 acid sequence includes an alanine at the N413 position .\n\ncomponent of the CRISPR - Cas9 system and the Cas9 pro-\n\nIn some embodiments , the modified protein includes one ,\n\ntein will not bind to or cleave the target DNA sequence\n\ntwo , or three mutations at the R245 , N419 or R654 positions\n\nwithout the downstream PAM sequence . The SaCas9 pro-\n\nin addition to a mutation at the N413 position . For example ,\n\ntein , for example , recognizes the canonical PAM sequence\n\nthe modified protein may include one or more mutations at\n\nNNGRRT or the non - canonical PAM sequence NNNRRT .\n\n60 R245 and / or N419 and a further mutation at R654 . In a\n\nNon - specific binding at locations other than the target\n\npreferred embodiment , the modified protein comprises an\n\nsequence , i.e. at off - target sites , of the CRISPR - Cas9 has\n\namino acid sequence as defined in SEQ ID NO : 3 or a\n\nbeen known to occur , thus resulting in cleaving of off - target\n\nhomologue thereof and includes a mutation at N413 , N419 ,", "type": "Document"}}